Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Find out information about products in our anti-infectives portfolio, including prescribing and safety information.
Products in our anti-infectives portfolio:
- Amoxil (amoxicillin)
- Augmentin (co-amoxiclav)
- Augmentin Duo (co-amoxiclav)
- Daraprim (pyrimethamine)
- Fortum (ceftazidime)
- Malarone (atovaquone/proguanil hydrochloride)
- Pentostam (sodium stibogluconate)
- Timentin (clavulanic acid/ticarcillin)
- Valtrex (valaciclovir)
- Wellvone (atovaquone)
- Zinacef (cefuroxime)
- Zinnat (cefuroxime axetil)
- Zovirax (aciclovir)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
Trade marks are owned by or licensed to the GSK group of companies.
